About Inspire MD

InspireMD introduces MGuardTM, a novel stent system that addresses Acute Coronary Syndromes. MGuard is based on a unique technology that minimizes distal embolization in complex thrombotic situations. The MGuard system is showing very successful results in clinical trials across Europe.

CE Mark

MGuard Coronary Stent has CE Mark approval to treat patients with coronary artery diseases and is sold across Europe, South America and Asia.

MGuard excels especially in patients with Acute MI and a large thrombotic mass. MGuard restores both the TIMI flow and excellent blush even in high risk patients. 
Current stenting practices are associated with adverse events: plaque destabilization; embolic showers and injury to the arterial wall which may lead to cardiac complications and ultimately death.
                             

MGuard provides a solution to these unmet needs:
• Plaque detachment/embolic showers during and post PCI procedure
• Injury to the arterial wall
• Restenosis
• Late thrombosis
• Patients contraindicated for Plavix

MGuard™ has been endorsed by leading interventional cardiologists worldwide as a potential breakthrough technology to reduce Major Adverse Cardiac Events (MACE). Click here for testimonials by the opinion leaders.

MGuard is not available for sale in the United States